Utah Medical Products (NASDAQ: UTMD) — Perfil da empresa, notícias e dados financeiros
Utah Medical Products develops medical devices for women's health and neonatal care, focusing on quality and patient outcomes.
Utah Medical Products
Utah Medical Products (NASDAQ:UTMD) specializes in developing, manufacturing, and distributing medical devices for the healthcare sector, focusing on needs in women's health, neonatal care, and urology. Their range includes innovative solutions like fetal monitoring systems, disposable and reusable pressure monitoring accessories, and catheters. Aimed at improving patient outcomes globally, Utah Medical Products is committed to quality, safety, and efficacy in healthcare through their offerings. The company's objective is to maintain and expand its product portfolio, ensuring it meets the evolving needs of medical professionals and patients around the world, while adhering to stringent regulatory standards.
Resumo
Operações
Produtos e/ou serviços de Utah Medical Products
- Blood pressure monitoring and blood collection devices, essential for accurate vascular health assessments.
- Electrosurgical generators and accessories, providing precise surgical outputs for various medical procedures.
- Intrauterine contraceptive devices, offering long-term, reversible contraception options.
- Neonatal intensive care products, designed to support the most vulnerable patients in critical early stages.
- OB/GYN and reproductive health products, addressing the comprehensive needs of women's health care.
- Gynecologic and electrosurgical instruments, facilitating a range of procedures with precision and efficiency.
equipe executiva do Utah Medical Products
- Kevin L. CornwellChairman, CEO, President & Secretary
- Brian L. KoopmanPrincipal Financial Officer, Accounting Manager & Controller
- Mark L. FoxVice President of Marketing
- Marcena H. ClawsonVice President of Corporate Sales
Últimas notícias sobre a Utah Medical Products
Histórico de dividendos
Dividendos por ação pagos pela Utah Medical Products, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.9300 |
| FY2025 | — | — | — | $1.2250 |
| FY2024 | — | — | — | $1.2050 |
| FY2023 | — | — | — | $1.1850 |
| FY2022 | — | — | — | $1.1650 |
Principais indicadores financeiros
Resultados divulgados pela Utah Medical Products, em USD.
- Cap. de mercado
- 232 mi
- Receita (TTM)
- 34,9 mi
- P/L
- 21.9
- LPA (diluído, TTM)
- 3.3
- Dividend yield
- 0.4%
- Margem de lucro
- 30.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 38,5 mi | 11,4 mi | 11,3 mi | |
| 40,9 mi | 13,6 mi | 13,9 mi | |
| 50,2 mi | 16,8 mi | 16,6 mi | |
| 52,3 mi | 19,8 mi | 16,5 mi |